dpp 4 inhibitors glp 1 Insight into Structure Activity Relationship of DPP-4 for Development of Antidiabetic Agents PDB-101: Diabetes Mellitus: Diabetes Mellitus:

The key is to document what you actually did so the maths matches your setup

placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1)

Solutions: Extend trial to 6 months before concluding inefficacy (some benefits take longer), increase dosing within safe ranges if using lower end, switch peptides (try Cerebrolysin if using BPC-157, or vice versa), add comprehensive eye exam to rule out progression versus peptide failure, consider peptides preventing worsening rather than producing improvement, discontinue if truly no benefit after 6 months rigorous trial

Whats the Link Between Glutathione and Aging

Is the procedure painful